eClinical Solutions Market For North America and Europe - Emerging Trends, Industry Forecast, Segmentation and Top Technologies
Key players in eClinical solutions market report are like Medidata Solutions, Inc. (US), PAREXEL International Corporation (US), and BioClinica, Inc. (US), OmniComm Systems, Inc. (US), DATATRAK International Inc. (US), ERT (US), Merge Healthcare Incorpora
(EMAILWIRE.COM, January 31, 2019 ) Geographically, North America commanded largest share of eClinical solutions market, followed by Europe. A number of factors like increasing government grants to support clinical trials, continuous product development and launch by eClinical solution vendors, growth in number of partnerships for new drug development, high prevalence of lifestyle diseases, & an increasing aging population are further stimulating demand for eClinical solutions in North America.
Download PDF Brochure of Global eClinical Solutions Market Report Now at http://www.reportsnreports.com/contacts/requestsample.aspx?name=187723 .
The global eClinical solutions market is estimated to reach 7.61 Billion by 2022, at a CAGR of 12.4% during the forecast period (2017-2022). Adoption of novel software solutions during clinical research and rising government funding to support clinical trials are key factors fueling the growth of the market.
The global eClinical solutions market is divided into phase I, phase II, phase III, and phase IV. The phase III clinical trials segment accounted for the largest share of the global eClinical solutions market in 2016. In addition, the phase III clinical trials segment is expected to grow at the highest CAGR during the forecast period. Report on eClinical solutions market covers software solutions used across all phases in clinical trial process. It aims at estimating market size and future growth potential of this market across different segments such as product type, delivery mode, clinical trial phase, end user, and regions.
The growth of the global eClinical solutions market is driven by factors such as a need for improved data standardization and an in creasein R&D expenditure by pharma-biotech companies with significant IT budgets for drug development. In addition, the rising number of clinical trials, especially across emerging countries in the Asia-Pacific region, offers growth opportunities for vendors of eClinical solutions.
#More Information on eClinical Solutions Market Report Now at <||>rnhttps://marketersmedia.com/eclinical-solutions-market-set-to-grow-at-124-cagr-to-2022-geographically-led-by-north-america-and-europe/472863 .
eClinical solutions market are focusing on partnerships, agreements, and collaborations as their key growth strategy, to maintain their position in the market and strengthen their revenue base. Companies also aim to differentiate themselves in the highly competitive eClinical solutions market by expanding their eClinical solutions portfolios in accordance with industry trends and client needs.
The eClinical solutions market is highly competitive, with a large number of global and local players. Oracle Corporation (U.S.) Medidata Solutions, Inc. (U.S.), and PAREXEL International Corporation (U.S.) were the top three players in the eClinical solutions market in 2018.
Key Target Audience
Healthcare IT Service Providers
eClinical Solution Vendors
Clinical Research Organizations
Pharmaceutical/Biopharmaceutical Companies
Research and Development (R&D) Companies
Business Research and Consulting Service Providers
Medical Research Laboratories
Academic Medical Centers/Universities/Hospitals
Venture capitalists and other government funding organizations
Market research and consulting firms
More Details on eClinical Solutions Market by Product (CDMS, EDC, CTMS, eCOA, Analytics, RTMS, eTMF, Safety), Delivery Mode (On-Demand, On-premise, Cloud-based), Clinical Trial Phases, End User (Pharma/Biopharma Companies, CROs, Hospitals) - Global Forecast to 2022 report @ http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=187723 .
Increasing operational costs and regulatory requirements associated with clinical research studies, government grants to support clinical trials, and increasing R&D expenditure by pharma-biotech companies with augmented IT budgets for drug development are some of the major driving factors for the global market.
Competitive Landscape
1 Overview
2 Market Share Analysis
3 Competitive Situation and Trends
4 Agreements, Partnerships, and Collaborations
5 Product Deployments
6 Product Launches & Product Enhancements
7 Mergers & Acquisitions
8 Expansions
The web-based delivery mode segment commanded the largest share of the global market. A number of factors such as easy user access, reductions in cost, and faster retrieval of data are responsible for its prominent market share. The cloud-based delivery mode segment is estimated to register the highest growth rate during the forecast period. The ease of integration, quicker deployment, and flexible scalability with a fixed monthly fee offered by cloud-based models are expected to drive the demand for these solutions.
Download PDF Brochure of Global eClinical Solutions Market Report Now at http://www.reportsnreports.com/contacts/requestsample.aspx?name=187723 .
The global eClinical solutions market is estimated to reach 7.61 Billion by 2022, at a CAGR of 12.4% during the forecast period (2017-2022). Adoption of novel software solutions during clinical research and rising government funding to support clinical trials are key factors fueling the growth of the market.
The global eClinical solutions market is divided into phase I, phase II, phase III, and phase IV. The phase III clinical trials segment accounted for the largest share of the global eClinical solutions market in 2016. In addition, the phase III clinical trials segment is expected to grow at the highest CAGR during the forecast period. Report on eClinical solutions market covers software solutions used across all phases in clinical trial process. It aims at estimating market size and future growth potential of this market across different segments such as product type, delivery mode, clinical trial phase, end user, and regions.
The growth of the global eClinical solutions market is driven by factors such as a need for improved data standardization and an in creasein R&D expenditure by pharma-biotech companies with significant IT budgets for drug development. In addition, the rising number of clinical trials, especially across emerging countries in the Asia-Pacific region, offers growth opportunities for vendors of eClinical solutions.
#More Information on eClinical Solutions Market Report Now at <||>rnhttps://marketersmedia.com/eclinical-solutions-market-set-to-grow-at-124-cagr-to-2022-geographically-led-by-north-america-and-europe/472863 .
eClinical solutions market are focusing on partnerships, agreements, and collaborations as their key growth strategy, to maintain their position in the market and strengthen their revenue base. Companies also aim to differentiate themselves in the highly competitive eClinical solutions market by expanding their eClinical solutions portfolios in accordance with industry trends and client needs.
The eClinical solutions market is highly competitive, with a large number of global and local players. Oracle Corporation (U.S.) Medidata Solutions, Inc. (U.S.), and PAREXEL International Corporation (U.S.) were the top three players in the eClinical solutions market in 2018.
Key Target Audience
Healthcare IT Service Providers
eClinical Solution Vendors
Clinical Research Organizations
Pharmaceutical/Biopharmaceutical Companies
Research and Development (R&D) Companies
Business Research and Consulting Service Providers
Medical Research Laboratories
Academic Medical Centers/Universities/Hospitals
Venture capitalists and other government funding organizations
Market research and consulting firms
More Details on eClinical Solutions Market by Product (CDMS, EDC, CTMS, eCOA, Analytics, RTMS, eTMF, Safety), Delivery Mode (On-Demand, On-premise, Cloud-based), Clinical Trial Phases, End User (Pharma/Biopharma Companies, CROs, Hospitals) - Global Forecast to 2022 report @ http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=187723 .
Increasing operational costs and regulatory requirements associated with clinical research studies, government grants to support clinical trials, and increasing R&D expenditure by pharma-biotech companies with augmented IT budgets for drug development are some of the major driving factors for the global market.
Competitive Landscape
1 Overview
2 Market Share Analysis
3 Competitive Situation and Trends
4 Agreements, Partnerships, and Collaborations
5 Product Deployments
6 Product Launches & Product Enhancements
7 Mergers & Acquisitions
8 Expansions
The web-based delivery mode segment commanded the largest share of the global market. A number of factors such as easy user access, reductions in cost, and faster retrieval of data are responsible for its prominent market share. The cloud-based delivery mode segment is estimated to register the highest growth rate during the forecast period. The ease of integration, quicker deployment, and flexible scalability with a fixed monthly fee offered by cloud-based models are expected to drive the demand for these solutions.
Contact Information:
ReportsnReports
Snehal
Tel: + 18883915441
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsnReports
Snehal
Tel: + 18883915441
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results